Join us on the 21st of this month as we explore the exciting field of cell therapies, including CAR-T and TCR-T cell therapies which display great potential to transform cancer treatment. This event will feature a keynote address by Novartis providing an overview of the topic of cell therapy and global developments in this area. A panel discussion by experts in the field will then delve into the details of the future promise of these therapies as well as current challenges in the field that may still need to be overcome.
Topics: MedTech / HealthTech / BioTech
Countless scientists are working on BioTech innovations in research laboratories globally, but how many of these scientists actually take their innovations out of the lab? According to Tech Crunch, BioTech companies were historically built by BioTech venture capital firms who founded and built the companies themselves. However, scientific founders leading the charge for bio companies are becoming the norm these days – scientists have become entrepreneurial scientists.
Topics: MedTech / HealthTech / BioTech, Startups
Startups and corporations alike are typically challenged by a dearth of healthcare data when determining pricing models and a unique value proposition to health systems. Hosted by ACCESS Health and SGInnovate, this event will discuss how data-driven partnerships can benefit startups in Singapore and discuss the features of a symbiotic relationship between healthcare operators, industry, and governments. The event aims to bring together all ecosystem stakeholders for knowledge sharing and networking purposes.
Topics: MedTech / HealthTech / BioTech
Healthcare is changing, and executives in MedTech and healthcare know that R&D, innovation and adoption of new technologies are crucial in ensuring that better healthcare is provided to patients. A survey by Forbes found that 80 per cent of executives in MedTech expect innovation to happen through partnerships, rather than in-house, with an increasing emphasis on open innovation, in which firms from diverse industries cooperate in some areas of research and development.
Topics: MedTech / HealthTech / BioTech
At near 85 years old, Singaporeans have one of the highest life expectancies in the world. For society as a whole, longevity can bring continued opportunities and contributions. However, this is highly dependant on the health of the citizens. An ageing and unhealthy population will burden the country's healthcare system and its economy.
Topics: MedTech / HealthTech / BioTech
With advancements in computing tools and the large amount of data collected, companies are relying on data science to make better business decisions. What if the algorithms and analytics that companies use to increase profit can be applied to improve social issues in healthcare and education, and to reap benefits for our society?
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, Data Science / Data Analytics, MedTech / HealthTech / BioTech
In this session, we will explore how data and tech are changing the face of healthcare and how these changes can lead to healthier lives.
Topics: Data Science / Data Analytics, MedTech / HealthTech / BioTech
Despite multiple studies showcasing how most ‘medical’ apps have little to no clinical research backing, there has been an influx of lifestyle and wellness apps flooding the market which offers illusionary benefits, faulty patient monitoring systems, and even wrong diagnosis. These apps often have exaggerated and unsubstantiated claims of condition monitoring, health benefits and treatments, making it difficult to differentiate and draw the line between apps and medical devices that actually helps patients.
Topics: MedTech / HealthTech / BioTech, RegTech
The rise of digital health has seen significant improvements to the quality of patient care - through improved patient compliance and availability of data collection, healthcare providers are now able to provide greater personalised care, early intervention, and better at-home care for patients.
Topics: MedTech / HealthTech / BioTech, Startups, Others
ACCESS Health International has partnered with Singapore Economic Development Board to conduct a joint study on the regionalisation of digital health innovation in Asia. The study identifies the pathway for digital health innovations to scale from Singapore to the rest of the region, identifies critical success factors and bottlenecks, and highlights the various strategies that digital health innovators have implemented to scale successfully in Asia. Through this invite-only event, we look to review the findings of the study and aim to catalyse new partnerships.
Topics: MedTech / HealthTech / BioTech
MedTech Marching towards a digital future: How should MedTech companies embrace digital innovation in Asia Pacific?
Topics: MedTech / HealthTech / BioTech
The focus on healthcare is shifting from reactive to proactive and predictive, human-centric care. How can we improve the overall health of a population and reduce healthcare costs using healthcare technology? The panel will share their perspectives on the future of population health management and the opportunities and challenges involved in leveraging healthcare technology to support population health.
Topics: MedTech / HealthTech / BioTech